Extended Data Fig. 9: Administration of MRC-Q does not alter body weight in NDUFS4-deficient mice.
From: Mitochondria transfer-based therapies reduce the morbidity and mortality of Leigh syndrome
Body weight of Ndufs4−/− mice treated with PBS or 50 µg MRC-Q once per week from 3- to 7-weeks old. Data are expressed as mean +/− SEM. All data points are unique biological replicates. n = 12 PBS, n = 14 MRC-Q. Data accompanies Fig. 4.
